Secondary Prevention

Secondary Prevention of Suicide

Leo Sher and colleagues discuss recent research on interventions to prevent secondary suicide and discuss the additional research that is needed.

Secondary prevention of stroke.

Stroke has been defined as a rapid onset of focal neurological deficit lasting more than 24 hours, with no apparent cause other than disruption of the blood supply to the brain (World Health Organization, 1989). A transient ischaemic attack (TIA) refers to a similar presentation that resolves within 24 hours (Hankey and Warlow, 1994). Approximately 15% of strokes are haemorrhagic, with the rest...

Prevention strategies for asthma--secondary prevention.

Antiplatelets in Secondary Stroke Prevention

The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention. The most commonly used antiplatelets agents are aspirin, clopidogrel, and extended-release dipyridamole. A lot of progress had been made in last years regarding aspirin resistance and genotyp...

Update of secondary stroke prevention.

Secondary prevention aims at preventing a stroke after a transient ischaemic attack (TIA) or a recurrent stroke after a first stroke. About 80–85% of patients survive a first ischaemic stroke [1,2]. Of those, between 8 and 15% suffer a recurrent stroke in the first year. The risk of stroke recurrence is highest in the first few weeks and declines over time [3–5]. The risk of recurrence depends ...